Clinical pharmacology in normal volunteers of praziquantel, a new drug against schistosomes and cestodes. An example of a complex study covering both tolerance and pharmacokinetics
about
Drugs for treating urinary schistosomiasisPharmacokinetic study of praziquantel administered alone and in combination with cimetidine in a single-day therapeutic regimenChanges in IgE- and antigen-dependent histamine-release in peripheral blood of Schistosoma mansoni-infected Ugandan fishermen after treatment with praziquantelThe redox biology of schistosome parasites and applications for drug developmentA multicentre randomized controlled trial of the efficacy and safety of single-dose praziquantel at 40 mg/kg vs. 60 mg/kg for treating intestinal schistosomiasis in the Philippines, Mauritania, Tanzania and BrazilTranscriptional responses of in vivo praziquantel exposure in schistosomes identifies a functional role for calcium signalling pathway member CamKIISelective indications for the use of praziquantel in the treatment of brain cysticercosisUse and safety of antimicrobial agents during pregnancy.Schistosomiasis chemotherapy.Human schistosomiasis resistance to praziquantel in China: should we be worried?Solid lipid nanoparticle suspension enhanced the therapeutic efficacy of praziquantel against tapeworm.Population Pharmacokinetics and Pharmacodynamics of Praziquantel in Ugandan Children with Intestinal Schistosomiasis: Higher Dosages Are Required for Maximal Efficacy.Praziquantel for the treatment of schistosomiasis: its use for control in areas with endemic disease and prospects for drug resistance.Transcriptional analysis of Schistosoma mansoni treated with praziquantel in vitro.Schistosoma mansoni P-glycoprotein levels increase in response to praziquantel exposure and correlate with reduced praziquantel susceptibilityTreatment of urinary schistosomiasis: methodological issues and research needs identified through a Cochrane systematic review.Pharmacokinetic variability of anthelmintics: implications for the treatment of neurocysticercosis.Routine drug and food interactions during antihelminthic treatment of neurocysticercosis: a reason for the variable efficacy of albendazole and praziquantel?Pharmacokinetic investigation of albendazole and praziquantel in Thai children infected with Giardia intestinalis.Pharmacokinetic interaction between ketoconazole and praziquantel in healthy volunteers.Comparative randomised trial of high and conventional doses of praziquantel in the treatment of schistosomiasis mansoni.[Neurocysticercosis in childhood. II. Computed tomography of 24 patients according to symptomatic and praziquantel treatment]Praziquantel in the cerebrospinal fluid in neurocysticercosis.Opinion of the Panel on additives and products or substances used in animal feed (FEEDAP) on the safety and efficacy of the product Bonvital, a preparation of Enterococcus faecium, as a feed additive for piglets and pigs for fattening in accordanc...Opinion of the Scientific Panel on Animal Health and Welfare (AHAW) regarding the assessment of the risk of Echinococcosis introduction into the UK, Ireland, Sweden, Malta and Finland as a consequence of abandoning national rulesIntestinal Lymphatic Delivery of Praziquantel by Solid Lipid Nanoparticles: Formulation Design,In VitroandIn VivoStudies
P2860
Q24241883-2B2DBB18-FB62-49C0-BDA6-041670B96797Q24670381-4AC52F55-B8EE-482E-B018-0DAC6759A1D3Q24802984-7916343B-1037-4A55-94FF-81141D33A29EQ26829701-E196A7EA-777F-4895-B185-DF2B3B09CD88Q28478552-946EE960-3768-44EA-BED1-586FF5AB7568Q28489110-E016B99B-94DC-4BA4-AD92-E45B60180B22Q33628105-B6D3DABC-8CC1-4136-9F5F-5929825A4A51Q34195656-B3F94022-362B-4975-9829-2C593318CEB3Q34354490-A914CDBC-0384-4B29-BEC8-D34CF2CD9550Q35065595-AA334747-0F06-4533-8CC8-21FFD0F6A49DQ35488086-EEDCEE5C-BFB6-4A19-9256-82790832CA5AQ36099895-0D9017C7-3B52-4FBC-A02E-916D70052237Q36441487-4B5E437A-E19D-4CEC-A757-240C3FE85B75Q36442593-2E9F8637-AF22-4E8B-9360-CC443B023245Q37223703-79E8000C-80D7-472E-8E62-6047B2CD0F7AQ37506661-C790A18B-9A03-4275-99B1-1A71470F223BQ37964749-4E11D4CC-7CC8-4648-AE69-9EF64099E404Q38180096-DFA7B6D1-8DE4-4BFA-88DA-9C927CC1D2A3Q39348194-2E9D3EEE-F044-405B-B66D-ECD0338093FCQ42637287-F0209BA4-085E-4E47-8F34-EFB4996F4965Q42933167-2FD199E6-5698-4A5E-B499-CC8ED743FF44Q44032708-FB442B7F-8573-4430-B828-0257DA6F7ADEQ44171317-6E9A3C89-1AE9-4737-BAD0-9A6B16BB049BQ47144641-4AD0D6C7-5944-4EAF-9351-B87FD8A2A02DQ47144644-7F260017-9B5B-416B-94A6-BBCCC8E27B92Q59060853-10F09055-CFFA-40CE-B3EC-C903701FC1D4
P2860
Clinical pharmacology in normal volunteers of praziquantel, a new drug against schistosomes and cestodes. An example of a complex study covering both tolerance and pharmacokinetics
description
1978 nî lūn-bûn
@nan
1978 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1978 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
name
Clinical pharmacology in norma ...... tolerance and pharmacokinetics
@ast
Clinical pharmacology in norma ...... tolerance and pharmacokinetics
@en
Clinical pharmacology in norma ...... tolerance and pharmacokinetics
@nl
type
label
Clinical pharmacology in norma ...... tolerance and pharmacokinetics
@ast
Clinical pharmacology in norma ...... tolerance and pharmacokinetics
@en
Clinical pharmacology in norma ...... tolerance and pharmacokinetics
@nl
prefLabel
Clinical pharmacology in norma ...... tolerance and pharmacokinetics
@ast
Clinical pharmacology in norma ...... tolerance and pharmacokinetics
@en
Clinical pharmacology in norma ...... tolerance and pharmacokinetics
@nl
P2093
P3181
P356
P1476
Clinical pharmacology in norma ...... tolerance and pharmacokinetics
@en
P2093
P2888
P304
P3181
P356
10.1007/BF00560463
P407
P577
1978-12-01T00:00:00Z
P6179
1018882268